chrisvoncsefalvay/vaers-outcomes huggingface dataset:
numbness in his fingers/right leg went numb; fog brain; aches and pains; This is a spontaneous report from a contactable consumer (patient's parent). A 53-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), dose 2 via an unspecified route of administration on an unspecified date (Batch/Lot Number: Unknown) (at the age of 53-years-old) as 2nd dose, single dose for COVID-19 immunisation. Medical history included cardiac pacemaker insertion. The patient's concomitant medications were not reported. Patient was previously administered with first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on an unspecified date (at the age of 53-years-old) for COVID-19 immunisation. The patient said that his son felt no real results from the second dose of COVID-19 vaccine shot but in 2 weeks his son had numbness in his fingers and what his son called fog brain. He said his son also had aches and pains and went to the Emergency Room. The caller said while in the Emergency Room, they drew blood from his son and couldn't find anything. He said his son has been to doctors and his son can't seem to get any help from his symptoms. He said yesterday, his son's right leg went numb. The caller said he was worried for his son and would like some medical help for his son. The patient's mother said they wanted information so her son won't die. The patient's father said his son had read a lot of people who received the COVID-19 vaccine and experienced side effects 2 weeks after the COVID-19 vaccine shot. The patient's father said it was almost exactly 2 weeks after his son received his second COVID-19 vaccine shot that his son experienced his weird problems. Outcome of events was unknown.  Information on the lot/batch number has been requested.
pt recv vax 15FEB99 & 2 days later pt devel yellow, watery diarrhea, vomiting & dec appetite;MD reportedly attributed this event to the flu;
3 days p/vax pt devel marked redness&swelling near inj site;c/o itching&some pain;had a f/u visit on 10APR96;@ that time upper arm lt w/erythema&urticaria extending from shoulder to almost elbow;rx of DPH
Fever, fatigue, headache, muscle aches, joint pain Home rest, ibuprofeno 2tab/6 hours since 4 pm 2/16/2021
Red circular raised rash, itchy and hot to the touch at injection site. Rash was approximately 1 inch in diameter at Initial onset. Rash grew to approximately 2 inches in diameter after 24 hours. All other symptoms remain unchanged.
Patient reported her arm was red the size of a softball, she reported it was warm to the touch, swollen and painful It was 4.5 days before it went away.
I received Moderna COVID vaccine at 1200pm on 12/24/2020 At about 0300 on 12/25/20, I awoke from sleeping with palpitations and a heart rate of about 140. Increased heart rate of 120-150 continued for a couple of hours with minimal dizziness. About 5am, I had a bought of sudden explosive, watery stool. This continued 3 more times in the am, at times having incontinence. (This has never occurred before.) By 10 am, those symptoms had stopped. Only residual side effects were a headache and sore arm. On 12/31, it was noticed that I had hives on my abdomen and back. They were not itchy and I am unsure how long they had been there for; referred to allergy
Fever, muscle aches, swollen gland under armpit, muscle cramps including vaginal cramping.
I have been dealing with hives since 11/5 that have only mildly responded to Zyrtec, Allegra and pepcid. I have been messaging with my allergist and I see him on Friday 11/17/23 for an in office visit
Received vaccine 11/17. On 11/18 he woke up with a sore arm and stomach ache. Very tired that day. By evening his left upper arm was very swollen, hot, red and painful. 11/19 he woke again with stomachache and arm was unchanged. Very tired again.  It is now evening 11/19 and his arm is red, hot, swollen and itchy. Still has a stomachache and fatigue.
sore arm; This is a spontaneous report from a Pfizer-sponsored program. A contactable consumer reported (patient wife) for a male patient (husband). A 73-years old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date as DOSE NUMBER UNKNOWN, SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. On an unspecified date caller reported that she and her husband had both doses of the Pfizer BCOVID19 vaccine and he had only experienced sore arm as side effect of the vaccine. The clinical outcome of event was unknown.    Information about lot/batch number has been requested.
This case was reported by a pharmacist via call center representative and described the occurrence of rash in a adult patient who received SHINGRIX for prophylaxis. On an unknown date, the patient received the 1st dose of SHINGRIX. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced rash. SHINGRIX was discontinued. On an unknown date, the outcome of the rash was unknown. It was unknown if the reporter considered the rash to be related to SHINGRIX. Additional details reported as follows: The age at vaccination was not reported. The age group was not reported but was selected as adult as per vaccine indication. The healthcare professional reported that patient would not be getting 2nd dose of SHINGRIX due to a rash from the 1st dose. The healthcare professional did not want to provide any additional information.
This spontaneous report was received from a healthcare worker and refers to a multiple unspecified patients of unknown age and gender with no pertinent medical history, concurrent condition or drug reaction/allergy. On an unknown date, the patients were vaccinated with improperly stored doses of GARDASIL (intramuscularly,  lot number reported as L044475, expiry date: 12-MAY-2017). There was no concomitant therapy. Reported temperature excursion was 34F within 8 hours. Data logger was involved. There was no previous temperature excursion. No treatment was given and no laboratory test diagnostic was performed. This is one of several reports from the same reporter. Additional information has been requested.
Nausea, diarrhea began morning after 2nd Pfizer shot on February 25,2021 Today's date is July 22,2021 (5 months of symptoms)
hot flashes; Rapid heartbeat; very deep breathing; Tight sore throat; Post nasal drip; Some coughing; This is a spontaneous report from a non-contactable consumer, the patient. A 63-year-old female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN), via an unspecified route of administration on 30Mar2021 at 14:15 (at the age of 63-years old) as a single dose for COVID-19 immunisation. Medical history included multiple sclerosis (MS). Concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unknown date in Mar2021, the patient experienced hot flashes, rapid heartbeat, very deep breathing with some coughing, tight sore throat and post nasal drip. The adverse events did not result in a visit to the doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events hot flashes, rapid heartbeat, very deep breathing, some coughing, tight sore throat and post nasal drip. The clinical outcomes of the events hot flashes, rapid heartbeat, very deep breathing, some coughing, tight sore throat and post nasal drip were resolving at the time of the report.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
patient didn't feel very well; patient was experiencing high temperature; This spontaneous case was reported by a patient and describes the occurrence of MALAISE (patient didn't feel very well) and PYREXIA (patient was experiencing high temperature) in a male patient of an unknown age who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Sep-2022, the patient received fifth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 19-Sep-2022, the patient experienced MALAISE (patient didn't feel very well) and PYREXIA (patient was experiencing high temperature). At the time of the report, MALAISE (patient didn't feel very well) and PYREXIA (patient was experiencing high temperature) outcome was unknown.            No concomitant medication was reported.    On an unknown date the patient received first dose with unknown lot number. On an unknown date the patient received second dose unknown lot number. On an unknown date the patient received first Moderna booster vaccine with unknown lot number. On an unknown date the patient received second Moderna booster vaccine with unknown lot number. Patient mentioned that with previous booster of Moderna COVID-19 Vaccine a few months ago, he didn't experience any side effects.  No treatment information was reported.
Inadvertent administration of adult Hepatitis A to a 17 year old young man.
The vaccine came in with 2 vials the mixing solutions and medication. The MA forget to mix the vials together and ended up with just giving the solutions.
Following day after vaccine in the morning I experienced Fatigue, Low grade fever 100.5, Chills and muscle ache. I was also very Tired. I took some tylenol. 1/7/21 Im feeling better temp 99.8
Within 3 1/2 hours of vaccines, vomited, crying. blood in stools, diarrhea x 2 weeks. Irritability lasted x 2 months.
8 hours after vaccine, maculo papular rash, fever, 102 degrees, rash persisted but fever resolved, baby is otherwise fine, eating and drinking well.
accidental overdose in reported in a pt receiving fluogen; pt has a hx of alzheimer's disease; This is 1 of 30 cases reported from this site; no adverse effects noted;
Sore arm; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 43 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 02Apr2021 19:00 (Lot number: EW0151) at the age of 43 years as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PAIN IN EXTREMITY (non-serious), outcome "unknown", described as "Sore arm". Relevant laboratory tests and procedures are available in the appropriate section.  No follow-up attempts are possible. No further information is expected.
Starting within the hour of my shot my left arm was very stiff and throbbing in pain. By 5pm I could not wiggle my fingers or even the slightest movement in my arm. At 7pm I started with a headache, complete body shakes, and a fever of 100. In the night it spiked to 102.6 All day Friday my fever stayed at 101-102.8. I had a bad headache and could not get any relief in my arm. My body ached and still had shakes from time to time. I took ibuprofen a couple of times to help with the pain and fever. By Saturday around 10am I had zero symptoms. Since then I have felt great.
This spontaneous report as received from a pharmacist refers to a 74 year old male patient, who approximately on 13-AUG-2013, reported as "7 to 8 days ago", was vaccinated with a dose of ZOSTAVAX (lot# and dose not reported). On an unspecified date, approximately in August 2013, the patient experienced "blockage in his ears". The patient sought medical attention, he was seen by doctor and prednisone (manufacturer unknown) 10 mg was prescribed, in a "tapering doses". At the time of report the outcome of patient and causality was not reported. Additional information has been requested.
Reddened area 2 inch by 2 inch, slightly warm to touch in the area where Varicella was given.
cough, loss of taste and smell, congestion, sore throat, nausea, fever
Woke with profuse sweating running a low grade fever 99.2, joint aches, and headache. Fever lasted until about 1200 but body/joint aches lasted all day on 10NOV2021.  On 12NOV2021, woke up nauseous and been naseous all day.
2nd dose given 25June2021 (more than 36 days from the 1st dose); This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (2nd dose given 25June2021 (more than 36 days from the 1st dose)) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 939676 and 022C21A) for COVID-19 vaccination.     Concurrent medical conditions included Arthritis, Fibrositis, Heartburn and Dry eyes. Concomitant products included FISH OIL for Dry eye, OMEPRAZOLE for Heartburn, MULTIVITAMINS [VITAMINS NOS] for an unknown indication.   On 11-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 25-Jun-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (2nd dose given 25June2021 (more than 36 days from the 1st dose)). On 25-Jun-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (2nd dose given 25June2021 (more than 36 days from the 1st dose)) had resolved.            No treatment medications were provided by the reporter.   This case was linked to MOD-2021-154239 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 28-Jul-2021: Non-significant follow-up appended On 31-Aug-2021: Patient details, Medical history and concomitant products updated
This spontaneous report was received from a office manager referring to a currently 59 year old female patient. Patient's medical history and concurrent conditions were not reported. On an unknown date, the patient was vaccinated with a single dose of PNEUMOVAX 23, (lot # L008664, expiry date 03-NOV-2016). On an unknown date the patient experienced pain in the arm of injection of PNEUMOVAX 23. The outcome of injection site pain was unknown. This is one of several reports from the same reporter source (MARRS # linked case 1510USA006195). Additional information has been requested.
injection arm itchy; injection arm kind of hurt; injection arm  swollen; big red rash in the injection arm; she did not feel good; aches; pain; headaches; This spontaneous case was reported by an other health care professional and describes the occurrence of MALAISE (she did not feel good), PAIN (aches), PAIN (pain), HEADACHE (headaches) and VACCINATION SITE PRURITUS (injection arm itchy) in a 45-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jan-2021, the patient experienced MALAISE (she did not feel good), PAIN (aches), PAIN (pain) and HEADACHE (headaches). On 29-Jan-2021, the patient experienced VACCINATION SITE PRURITUS (injection arm itchy), INJECTION SITE PAIN (injection arm kind of hurt), INJECTION SITE SWELLING (injection arm  swollen) and INJECTION SITE RASH (big red rash in the injection arm). At the time of the report, MALAISE (she did not feel good), PAIN (aches), PAIN (pain), HEADACHE (headaches), VACCINATION SITE PRURITUS (injection arm itchy), INJECTION SITE PAIN (injection arm kind of hurt), INJECTION SITE SWELLING (injection arm  swollen) and INJECTION SITE RASH (big red rash in the injection arm) had resolved. Not Provided    The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter.  No treatment medication was reported.
82 year old female presenting with fever, cough and wheezing for 2 days.  Symptoms unchanged.  No sick contacts or exposures.  Taking tylenol with symptom relief.  Hx HTN and COPD.  Non smoker.  Not using rescue inhaler.  Had flu shot.  Had 2nd covid vaccine on 3/6/2021/  No prior covid infection.  COVID positive
Pt. requested a Bivalent Covid vaccine.  Pt.  was called and advised that she was given a monovalent and not Bivalent.   Pt. advised she would need to wait 2 months before a Bivalent could be given.
no additional AEs reported; GARDASIL 9 were administered to multiple unknown patients following temperature excursion; This non-valid, spontaneous report was received from an office manager and referred to multiple patients of unknown age and gender. The patients' concurrent conditions, concomitant therapies and medical history was not provided.  On an unknown date, multiple patients were vaccinated with hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) pre-filled syringe, injection, 1 dose, lot # and expiration dates: 1775811, 07-DEC-2023; 1775827, 27-JUN-2024; W009829, 19-OCT-2024; U032681, 26-OCT-2023; and 1780876, 09-NOV-2023 (administration sites, and routes of administration were not provided) administered for prophylaxis.On unknown dates, the doses of vaccines experienced the temperature excursions of 8.55 Celsius degrees for 8 minutes and 9.29 Celsius degrees for 12 minutes (product storage error). There were no previous excursions reported. No additional adverse event (AE) details were reported (no adverse event).  This report is non-valid due to lack of patients' identifiers.  Follow-up information was received from an office manager on 10-MAY-2023:  The patient identifiers was updated such as date of birth, address and gender.  On 23-FEB-2023, the patient was vaccinated with one dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) pre-filled syringe, injection, 1 dose, lot # and expiration dates: 1775811, 07-DEC-2023; 1775827, 27-JUN-2024; W009829, 19-OCT-2024; U032681, 26-OCT-2023; and 1780876, 09-NOV-2023 (administration sites, and routes of administration were not provided) administered for prophylaxis.  Temperature excursion total time was 25 minutes. There was 3 temperature excursions: on 09-SEP-2022 for 8 minutes, on 16-SEP-2022 for 5 minutes and on 03-JAN-2023 for 12 minutes. Excursions were not noted until after the first fact due to employee error of cleaning data logger more than once a day.  The vaccines was purhased with public and privet founds and were given in private doctor's office/ hospital.The medication error occurred in the point of storage in clinical practice.  This one of the several reports received from the same reporter. ; Sender's Comments:  US-009507513-2304USA002221:
No adverse effects were reported; 25 year old female patient was administered one dose of PROQUAD; This spontaneous report was received from a medical assistant and refers to a 25-year-old female patient. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided. On 17-APR-2019, the patient was vaccinated with a dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) recombinant Human albumin (rHA), lot # R014354, expiration date: 18-NOV-2019 for prophylaxis (route of administration and vaccination site were not reported) reconstituted with sterile diluent. No adverse effects were reported.
Upon waking at 0600 on 5/21/21 - experiencing dizziness, weakness, lightheadedness, and fainting twice within five minute time span upon waking. Day continued on with dizziness and weakness. Dizziness subsided a few hours later, weakness lasted all day. Treatment - resting, fluids, and limited time standing. Outcome - weakness and times of lightheadedness occurred for 1-2 weeks after vaccine.
This medically confirmed spontaneous report (initial receipt: 26-Feb-2016) concerns a 61 year-old female patient. On 18-Sep-2015, the patient received AFLURIA (batch number U55406; expiry date: 30-Jun-2016 yet reported as 12-Jun-2016). The AFLURIA vaccine was stored at 0.6 to 1.1 degree Celsius (reported as 33-34 degrees Fahrenheit) multiple times. The last excursion was 0 degrees Celsius (reported as 32 degrees Fahrenheit) for no more than 24 hours. The outcome was not reported.
(LT) upper arm weak & numb x 6 days from deltoid to elbow.  Reoccured with Gardasil #2 - (RT) arm, marked pain + weakness - RT upper arm - 5 days (injection sites - ok)
Hives appeared on left arm evening after shot was given & patient had temp (rectal) of 102.5 degrees F.  MOTRIN, TYLENOL & BENADRYL given by mother around the clock.  Saw pediatrician 10/4/08.
On 04/10/2021, the day after the vaccine, a lack of energy started right away. Around May 2021, I started to have a lot of pain. On June 04, 2021 I had hernia surgery. Pre surgery the doctor told me I did have a hernia. He told me the pain I was feeling was not caused by the hernia. The pain I am feeling  radiates from my right upper inner thigh through my groin, across the side of my lower end of my back. 10/11/2021 The doctor did a nerve block and prescribed muscle relaxers. The muscle relaxers have not helped the pain. We are going to give the muscle relaxers 10 days to work. If in 10 days the muscle relaxer do not relieve the pain ,  the doctor is going to order an MRI.
Patient came to pharmacy having concerns about his health for getting 2 moderna vaccines less than 28 days. We checked his vaccine card and found out that he got his 1st dose at the pharmacy on 4/27/2021 and 2nd dose at the store on 5/1/2021. He reports of feeling dizzy and drowsy.
I gave Meningococcal B instead of the Meningococcal polysaccharide.  No adverse reacation
Patient was present in clinic for Covid 19 vaccine, first dose. Patient completed Covid 19 consent form stating he had a confirmed diagnosis of Covid 19 days in the last 90 days. Patient was allowed to receive vaccine. After vaccination, while documenting on his medical record, mistake was discovered. Upon review of the record, noted patient tested positive for COVID 19 on 12/17/2020. On 12/30/2020 patient presented to clinic for the COVID 19 vaccination; he completed the facility's COVID vaccination consent form and the COVID Moderna vaccine screening form.  12/31/2020 @ 1304 Order placed for vaccine LPN and signed off by Dr.
COVID 19 treatment; COVID 19 treatment; This is a spontaneous report received from a non-contactable reporter (Consumer or other non HCP) from product quality group. The reporter is the patient.  A 64-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 04Nov2022 as dose number unknown (booster), single (Lot number: GJ6665) at the age of 64 years, in left arm for COVID-19 immunisation; COVID-19 vaccine (COVID-19 VACCINE), as dose number unknown, single (Batch/Lot number: unknown) for COVID-19 immunisation. The patient's relevant medical history included: "Known allergies: penicillins" (unspecified if ongoing); "Known allergies: tree nuts" (unspecified if ongoing). Concomitant medication included: ESTRADIOL, start date: Dec2014, stop date: Apr2023. Past drug history included: Toradol, reaction: "Known allergies: Toradol". The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "COVID 19 treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive. Therapeutic measures were taken as a result of drug ineffective, COVID-19 which included Paxlovid from 29Mar2023 to 03Apr2023. Clinical course: The patient's symptoms had abated on Day 5 with end of Paxlovid course and felt recovered on morning of Day 9, but by afternoon runny nose developed.  No follow-up attempts are possible. No further information is expected.